Literature DB >> 8564110

Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients.

I de Godoy1, M Donahoe, W J Calhoun, J Mancino, R M Rogers.   

Abstract

The inflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-1-beta (IL-1 beta), have been associated with accelerated metabolism and protein turnover following exogenous administration in normal humans. We hypothesized that these inflammatory cytokines might contribute to the weight-losing process in patients with chronic obstructive pulmonary disease (COPD). COPD patients were identified prospectively as "weight losers" (WL; n = 10) if they reported > 5% weight loss during the preceding year or as "weight stable" (WS; n = 10) if their body weight fluctuated < or = 5%. Age-matched healthy volunteers were selected as the control group (C; n = 13). Monocytes were isolated from a peripheral blood sample, cultured, and exposed to lipopolysaccharide (LPS). The concentration of TNF-alpha and IL-1 beta in the monocyte supernatant was measured using a four layer enhanced ELISA. No significant difference in LPS-stimulated IL-1 beta production was found in the three study populations. However, LPS-stimulated TNF-alpha production (mean [range] ng/ml) by monocytes was significantly higher in the WL COPD patients (20.2 [6.3 to 44.8]), compared with WS patients (6.9 [1.5 to 16.6]), and C subjects (5.7 [0 to 61.8]). This difference was not maintained at 6 mo follow-up in the absence of ongoing weight loss. Definition of a causal relationship between TNF-alpha production and weight loss will require further understanding of the relationship between energy metabolism and TNF-alpha production in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564110     DOI: 10.1164/ajrccm.153.2.8564110

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  56 in total

1.  Circulating TNF alpha receptor levels identify older adults who fail to regain weight after acute weight loss.

Authors:  M Yukawa; J Brown-Chang; H S Callahan; C F Spiekerman; D S Weigle
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

Review 2.  [Comorbidities of COPD].

Authors:  H Watz; H Magnussen
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

3.  NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy.

Authors:  Ramon C J Langen; Astrid Haegens; Juanita H J Vernooy; Emiel F M Wouters; Menno P J de Winther; Harald Carlsen; Chad Steele; Steven E Shoelson; Annemie M W J Schols
Journal:  Am J Respir Cell Mol Biol       Date:  2012-04-26       Impact factor: 6.914

4.  Systemic inflammation and progression of COPD.

Authors:  Jørgen Vestbo
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

Review 5.  Chronic obstructive pulmonary disease * 12: New treatments for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

6.  Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.

Authors:  Fisun Karadag; Aslihan B Karul; Orhan Cildag; Mustafa Yilmaz; Hatice Ozcan
Journal:  Lung       Date:  2008-09-20       Impact factor: 2.584

7.  Elevated TNFalpha production in whole blood in patients with severe COPD: the potential link to disease severity.

Authors:  Stephan von Haehling; Nicholas S Hopkinson; Michael I Polkey; Margit Niethammer; Stefan D Anker; Sabine Genth-Zotz
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

8.  Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities.

Authors:  Nicola J Sinden; Robert A Stockley
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

9.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

Review 10.  Malnutrition and ageing.

Authors:  M Hickson
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.